Osteonecrosis in Gaucher Disease in the era of multiple therapies: biomarker set for risk stratification from a tertiary referral center
Mohsen Basiri, Mohammad Ebrahim Ghaffari, Jiapeng Ruan, Vagishwari Murugesan, Nathaniel Kleytman, Glenn S. Belinsky, Amir Akhavan, Andrew W. Lischuk, Lilu Guo, Katherine Wood Klinger, Pramod Kumar Mistry
This study identifies biomarkers predicting avascular osteonecrosis risk in Gaucher disease patients on enzyme replacement or substrate reduction therapy.
eLife · May 30, 2023Peer-reviewedGenetic & Genomic Medicine